Tag: NASDAQ: MNOV

Business

Medicinova, Inc (NASDAQ: MNOV) And BARDA Reach Agreement To Conduct Mice Study To Develop MN-166 (Ibudilast)

Medicinova, Inc (NASDAQ: MNOV) struck a partnership with BARDA in a quest to manufacture a new substance called MN-166(ibudilast). It hopes that the development of the new product will serve as an effective countermeasure to make life more bearable for patients struggling with chlorine gas-induced lung injury.  The study geared towards […]